Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) today announced that it has signed an agreement with an international biopharmaceutical company to assess the potential of PBIO’s recently acquired PreEMT™ platform to develop a unique manufacturing process and improve the quality of a key protein-based drug that’s currently under development. “We believe this contract … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Agreement Related to Recently Acquired PreEMT™ Platform”
Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that Richard T. Schumacher, the company’s president and CEO, will be hosting a webinar update and live Q&A session for investors today at 3:00 pm EDT. Per the update, the webinar will include discussions on enhancements made to products in PBIO’s core Research … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO to Host Webinar on May 2”
Pressure BioSciences (OTCQB: PBIO) recently announced newly-issued patents in Ultra Shear Technology (“UST”) that address broad markets for stable, water-soluble nanoemulsions, including cannabinoids. An article further discussing the company reads: “With the BaroFold acquisition and the new developments in Ultra Shear Technology (including two issued patents), Pressure BioSciences now has three distinct working groups — … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Sees 2018 as Year of Growth for BaroFold, Ultra Shear Technology Programs”
Record product sales growth reported for fourth quarter and full year 2017 Company has over 300 of its ultra-high pressure instruments in research labs worldwide 2017 revenue exceeded $2.2 million with just one field sales rep; company’s field sales force expanded to five with recent hires December 2017 acquisition of high pressure IP allows company … Continue reading “Pressure BioSciences Inc.’s (PBIO) New Products and Enhanced Sales Capabilities Drive Plans for Banner 2018”
Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2017. The company also provided a business update and offered limited guidance for FY2018. Among the highlights, PBIO reported $502,708 in total revenue for the three-month period, marking a year-over-year increase … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces FY2017 Financial Results”
Global life sciences company Pressure BioSciences, Inc. (OTCQB: PBIO) this morning announced that it plans to host a teleconference to discuss its fourth quarter and fiscal year 2017 financial results and to provide a business update. The teleconference is scheduled for Tuesday, April 3, 2018, at 4:30 PM EDT. Those interested in participating in the … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Sets Teleconference to Discuss FY2017 Results”
Amid the growing demand for nanoemulsions, Pressure BioSciences (OTCQB: PBIO) boasts a patented novel technique called Ultra Shear Technology (“UST”). UST process produces highly stable, clean and cost-effective nanoemulsions. An article further discussing the company’s technology reads: “To date, cost-effective, highly stable nanoemulsions made with minimal or no surfactants have been difficult to produce. Pressure … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Novel Technology Enables Industrial Level Production of Nanoemulsions”
Patented UST process produces highly stable, clean and cost-effective nanoemulsions Technology can be applied across many industries, including pharmaceutical, food, nutraceutical, industrial lubricant, paint and cosmetic sectors UST technology aligns with consumer demand for chemical- and preservative-free products The demand for nanoemulsions is growing at a fast pace, with potential applications in many industry sectors, … Continue reading “Pressure BioSciences’ (PBIO) Patented Tech Enhances Nanoemulsion Bioavailability and Extends Product Shelf Life”
Pressure BioSciences (OTCQB: PBIO) recently entered a global co-marketing and distribution agreement with ISS, Inc. to create an advanced high pressure optical spectroscopy system utilizing PBIO’s patented pressure cycling technology (“PCT”). An article further discussing the agreement reads: “A leading developer and provider of innovative high pressure-based solutions to the global life sciences industry, Pressure … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Agreement to Create Unique Analytical System Using Patented Pressure Cycling Technology”
Pressure BioSciences’ (OTCQB: PBIO) patented technology may provide the ideal transport for CBD and other cannabinoids. The company’s novel Ultra Shear Technology (“UST) has the capacity to develop water-soluble nanoemulsions that can be employed to improve the bioavailability of cannabinoids. An article discussing the company reads: “Nanoemulsions offer an advanced mode of drug delivery that’s … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Technology Could Provide Ideal Drug Delivery of Cannabinoids”
